Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of α-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome

British Journal of Nutrition

Volumn 108, Issue 4, 2012, Pages 682-691

  Baxheinrich, Andrea ^a   Stratmann, Bernd ^b   Lee Barkey, Young Hee ^b   Tschoepe, Diethelm ^b   Wahrburg, Ursel ^a  

^a MÜNSTER UNIVERSITY OF APPLIED SCIENCES   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Linolenic acid; Dietary therapy; Metabolic syndrome; Rapeseed oil; Weight reduction

Indexed keywords

LINOLENIC ACID; MONOUNSATURATED FATTY ACID; OLIVE OIL; OMEGA 3 FATTY ACID; RAPESEED OIL; TRIACYLGLYCEROL;

ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DIET; DIET THERAPY; FAT INTAKE; FEMALE; FOOD COMPOSITION; HUMAN; HYPOENERGETIC DIET; MACRONUTRIENT; MALE; METABOLIC SYNDROME X; PARALLEL DESIGN; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; ALPHA-LINOLENIC ACID; BRASSICA RAPA; CARDIOVASCULAR DISEASES; DIET, REDUCING; FEASIBILITY STUDIES; FEMALE; GERMANY; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT DROPOUTS; PLANT OILS; PREVALENCE; RISK FACTORS; SEEDS; WEIGHT LOSS;

EID: 84865241314     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512002875     Document Type: Article

References (61)

1. Alberti K, Eckel RH, Grundy S, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International. Circulation 120, 1640-1645.
2. Lichtenstein AH, Appel LJ, Brands M, et al. (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114, 82-96. (Pubitemid 44305278)
3. Vessby B, Uusitupa M, Hermansen K, et al. (2001) Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia 44, 312-319. (Pubitemid 32234457)
4. Bes-Rastrollo M, van Dam RM, Martinez-Gonzalez MA, et al. (2008) Prospective study of dietary energy density and weight gain in women. Am J Clin Nutr 88, 769-777.
5. Kant AK & Graubard BI (2005) Energy density of diets reported by American adults: association with food group intake, nutrient intake, and body weight. Int J Obes 29, 950-956. (Pubitemid 41076235)
6. National Institutes of Health (2000) Weight management techniques. In The Practical Guide. Identification, Evaluation, and Treatment of Overweight and Obesity in Adults, pp. 26-27. NIH Publication no. 00-4084. Bethesda, MD: US Department of Health and Human Services.
7. Cummings S, Parham ES & Strain GW (2002) Position of the American Dietetic Association: weight management. J Am Diet Assoc 102, 1145-1155. (Pubitemid 40434144)
8. Hu FB (2010) Are refined carbohydrates worse than saturated fat? Am J Clin Nutr 91, 1541-1542.
9. Finley CE, Barlow CE, Halton TL, et al. (2010) Glycemic index, glycemic load, and prevalence of the metabolic syndrome in the cooper center longitudinal study. J Am Diet Assoc 110, 1820-1829.
10. Griel AE, Ruder EH & Kris-Etherton PM (2006) The changing roles of dietary carbohydrates: from simple to complex. Arterioscler Thromb Vasc Biol 26, 1958-1965. (Pubitemid 44255503)
11. Jakobsen MU, Dethlefsen C, Joensen AM, et al. (2010) Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am J Clin Nutr 91, 1764-1768.
12. Herder C, Peltonen M, Koenig W, et al. (2009) Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study. Diabetologia 52, 433-442.
13. Ledikwe JH, Blanck HM, Khan LK, et al. (2006) Low-energydensity diets are associated with high diet quality in adults in the United States. J Am Diet Assoc 106, 1172-1180. (Pubitemid 44079972)
14. Roberts SB, McCrory MA & Saltzman E (2002) The influence of dietary composition on energy intake and body weight. J Am Coll Nutr 21, 140S-145S. (Pubitemid 38622949)
15. Gillingham LG, Harris-Janz S & Jones PJH (2011) Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids 46, 209-228.
16. Sofi F, Abbate R, Gensini GF, et al. (2010) Accruing evidence about benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 92, 1189-1196.
17. Shai I, Schwarzfuchs D, Henkin Y, et al. (2008) Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 359, 229-241. (Pubitemid 352008438)
18. Esposito K, Malorino MI, Ciotola M, et al. (2009) Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes. Ann Intern Med 151, 306-314.
19. Due A, Larsen TM, Mu H, et al. (2008) Comparison of 3 ad libitum diets for weight-loss maintenance, risk of cardiovascular disease, and diabetes: a 6-mo randomized, controlled trial. Am J Clin Nutr 88, 1232-1241.
20. Kirk JK, Graves DE, Craven TE, et al. (2008) Restrictedcarbohydrate diets in patients with type 2 diabetes: a metaanalysis. J Am Diet Assoc 108, 91-100. (Pubitemid 350296011)
21. Ros E (2003) Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes. Am J Clin Nutr 78, 617S-625S. (Pubitemid 40012556)
22. Zivkovic AM, German JB & Sanyal AJ (2007) Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 86, 285-300. (Pubitemid 47256910)
23. Nettleton JA & Katz R (2005) n-3 Long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc 105, 428-440. (Pubitemid 40326734)
24. Riediger ND, Othman RA, Suh M, et al. (2009) A systemic review of the roles of n-3 fatty acids in health and disease. J Am Diet Assoc 109, 668-679.
25. Stark AH, Crawford MA & Reifen R (2008) Update on alphalinolenic acid. Nutr Rev 66, 326-332.
26. Robinson LE, Buchholz AC & Mazurak VC (2007) Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome. Appl Physiol Nutr Metab 32, 1008-1024.
27. Paschos G, Magkos F, Panagiotakos DB, et al. (2007) Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients. Eur J Clin Nutr 61, 1201-1206. (Pubitemid 47521552)
28. Bloedon LT, Balikai S, Chittams J, et al. (2008) Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr 27, 65-74. (Pubitemid 351600524)
29. Barre DE, Mizier-Barre KA, Griscti O, et al. (2008) High dose flaxseed oil supplementation may affect fasting blood serum glucose management in human type 2 diabetics. J Oleo Sci 57, 269-273.
30. Alberti K, Zimmet P & Shaw J (2005) The metabolic syndrome - a new worldwide definition. Lancet 366, 1059-1062. (Pubitemid 41338752)
31. Hauner H, Buchholz G, Hamann A, et al. (2007) Evidenzbasierte Leitlinie Prävention und Therapie der Adipositas (Evidence-based Guideline for the Prevention and Treatment of Obesity). München: Deutsche Adipositas-Gesellschaft, Deutsche Diabetes-Gesellschaft, Deutsche Gesellschaft für Ernährung, Deutsche Gesellschaft für Ernährungsmedizin pp. 10-12.
32. Ello-Martin JA, Roe LS, Ledikwe JH, et al. (2007) Dietary energy density in the treatment of obesity: a year-long trial comparing 2 weight-loss diets. Am J Clin Nutr 85, 1465-1477. (Pubitemid 46890413)
33. Ledikwe JH, Rolls BJ, Smiciklas-Wright H, et al. (2007) Reductions in dietary energy density are associated with weight loss in overweight and obese participants in the PREMIER trial. Am J Clin Nutr 85, 1212-1221. (Pubitemid 46740461)
34. Rolls BJ, Roe LS, Beach AM, et al. (2005) Provision of foods differing in energy density affects long-term weight loss. Obes Res 13, 1052-1060.
35. Digenio AG, Mancuso JP, Gerber RA, et al. (2009) Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial. Ann Intern Med 150, 255-262.
36. Appel LJ, Brands MW, Daniels SR, et al. (2006) Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 47, 296-308. (Pubitemid 43189776)
37. Sacks F & Campos H (2010) Dietary therapy in hypertension. N Engl J Med 362, 2102-2112.
38. Reaven GM (2005) The insulin resistance syndrome: definition and dietary approaches to treatment. Ann Rev Nutr 25, 391-406. (Pubitemid 41209007)
39. Estruch R, Martínez-González MA, Corella D, et al. (2006) Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 145, 1-11. (Pubitemid 46780599)
40. Elhayany A, Lustman A, Abel R, et al. (2010) A low carbohydrate Mediterranean diet improves cardiovascular risk factors and diabetes control among overweight patients with type 2 diabetes mellitus: a 1-year prospective randomized intervention study. Diabetes Obes Metab 12, 204-209.
41. Egert S, Kratz M, Kannenberg F, et al. (2011) Effects of highfat and low-fat diets rich in monounsaturated fatty acids on serum lipids, LDL size and indices of lipid peroxidation in healthy non-obese men and women when consumed under controlled conditions. Eur J Nutr 50, 71-79.
42. Jebb SA, Lovegrove JA, Griffin BA, et al. (2010) Effect of changing the amount and type of fat and carbohydrate on insulin sensitivity and cardiovascular risk: the RISCK (Reading, Imperial, Surrey, Cambridge, and Kings) trial. Am J Clin Nutr 92, 748-758.
43. Gerhard GT, Ahmann A, Meeuws K, et al. (2004) Effects of a low-fat diet compared with those of a high-monounsaturated fat diet on body weight, plasma lipids and lipoproteins, and glycemic control in type 2 diabetes. Am J Clin Nutr 80, 668-673. (Pubitemid 41115532)
44. Rallidis LS, Lekakis J, Kolomvotsou A, et al. (2009) Close adherence to a Mediterranean diet improves endothelial function in subjects with abdominal obesity. Am J Clin Nutr 90, 263-268.
45. Rumawas ME, Meigs JB, Dwyer JT, et al. (2009) Mediterranean- style dietary pattern, reduced risk of metabolic syndrome traits, and incidence in the Framingham Offspring Cohort. Am J Clin Nutr 90, 1608-1614.
46. Esposito K, Marfella R, Ciotola M, et al. (2004) Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292, 1440-1446. (Pubitemid 39258336)
47. Welch AA, Shakya-Shrestha S, Lentjes MA, et al. (2010) Dietary intake and status of n-3 polyunsaturated fatty acids in a population of fish-eating and non-fish-eating meat-eaters, vegetarians, and vegans and the precursor-product ratio of a-linolenic acid to long-chain n-3 polyunsaturated fatty acids: results. Am J Clin Nutr 92, 1040-1051.
48. Kris-Etherton PM, Taylor DS, Yu-Poth S, et al. (2000) Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 71, 179S-188S. (Pubitemid 30046114)
49. Harris WS, Miller M, Tighe AP, et al. (2008) Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 197, 12-24.
50. Lavie CJ, Milani RV, Mehra MR, et al. (2009) Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol 54, 858-894.
51. Zatonski W, Campos H & Willett W (2008) Rapid declines in coronary heart disease mortality in Eastern Europe are associated with increased consumption of oils rich in alpha-linolenic acid. Eur J Epidemiol 23, 3-10.
52. Djoussé L, Arnett DK, Carr JJ, et al. (2005) Dietary linolenic acid is inversely associated with calcified atherosclerotic plaque in the coronary arteries: the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 111, 2921-2926. (Pubitemid 40814184)
53. Sala-Vila A, Cofán M, Pérez-Heras A, et al. (2010) Fatty acids in serum phospholipids and carotid intima-media thickness in Spanish subjects with primary dyslipidemia. Am J Clin Nutr 92, 186-193.
54. Kromhout D, Giltay EJ & Geleijnse JM (2010) n-3 Fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 363, 2015-2026.
55. Finnegan YE, Minihane AM, Leigh-Firbank EC, et al. (2003) Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J Clin Nutr 77, 783-795.
56. Zhao G, Etherton TD, Martin KR, et al. (2004) Dietary a-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 134, 2991-2997. (Pubitemid 39470074)
57. Schwab US, Callaway JC, Erkkilä AT, et al. (2006) Effects of hempseed and flaxseed oils on the profile of serum lipids, serum total and lipoprotein lipid concentrations and haemostatic factors. Eur J Nutr 45, 470-477. (Pubitemid 46020598)
58. Seppänen-Laakso T, Laakso I, Lehtimäki T, et al. (2010) Elevated plasma fibrinogen caused by inadequate alpha-linolenic acid intake can be reduced by replacing fat with canola-type rapeseed oil. Prostaglandins Leukotr Essent Fatty Acids 83, 45-54.
59. Kaul N, Kreml R, Austria JA, et al. (2008) A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers. J Am Coll Nutr 27, 51-58. (Pubitemid 351600522)
60. Goyens PLL & Mensink RP (2006) Effects of alpha-linolenic acid versus those of EPA/DHA on cardiovascular risk markers in healthy elderly subjects. Eur J Clin Nutr 60, 978-984. (Pubitemid 44161019)
61. Egert S, Kannenberg F, Somoza V, et al. (2009) Dietary alphalinolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. J Nutr 139, 861-868.